Srdjan R. Stankovic, President at ACADIA PHARMACEUTICALS INC (ACAD), sold 700 shares at $55.01 ($39K) on 2021-01-12, disclosed to the SEC on 2021-01-14.
Scheduled sale ($39k) by President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ACAD | SELL | 2022-05-03 | $104K | — | Filing → |
| ACAD | SELL | 2022-02-25 | $36K | — | Filing → |
| ACAD | SELL | 2022-01-10 | $45K | — | Filing → |